Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

15.35
Delayed Data
As of Apr 28
 0.00 / 0.00%
Today’s Change
12.21
Today|||52-Week Range
24.00
+17.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues0.000.000.001.3M
 
 
Cost of Goods Sold0.000.000.0035.0K
 
 
Depreciation And Amortization238.0K251.0K304.0K306.0K
 
 
 
 
 
 
Operating ExpensesGross Income-238.0K-251.0K-304.0K938.0K
 
 
 
 
 
General Expenses33.1M42.8M42.2M47.7M
 
 
 
 
 
Research And Development16.1M27.3M25.5M29.5M
 
 
 
 
 
Total Operating Expenses33.3M43.1M42.5M48.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.3M-43.1M-42.5M-46.8M
 
 
 
 
 
Extraordinary Charge0.000.00-5.2M--
 
 
Interest Expense On Debt133.0K160.0K--1.6M
 
 
 
 
Other Expenses0.000.00-775.0K436.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.4M-43.2M-48.5M-48.0M
 
 
 
 
 
Net Income-33.4M-43.2M-48.5M-48.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.2M37.0M39.1M39.3M
 
 
 
 
 
Shares To Calculate EPS Diluted36.2M37.0M39.1M39.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.92-$1.17-$1.24-$1.22
 
 
 
 
 
EPS Diluted-$0.92-$1.17-$1.24-$1.22